10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Eukaryotic cells play a crucial role in the development and implementation of antimicrobial strategies. Within these cells, intricate processes and mechanisms are at work to combat microbial threats. One significant aspect is the role of eukaryotic cells in the immune response. Immune cells, such as macrophages and neutrophils, are eukaryotic in nature and act as front-line defenders against invading microorganisms. These cells employ various antimicrobial mechanisms, including phagocytosis, where the pathogens are engulfed and subsequently destroyed within the cellular compartments. Moreover, eukaryotic cells contribute to the synthesis and release of antimicrobial peptides (AMPs). These peptides play a crucial role in the innate immune system, providing a rapid and broad-spectrum defense against various microbes. Eukaryotic cells, especially those in epithelial tissues, produce AMPs in response to microbial invasion, forming a critical component of the cellular defense arsenal.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria